Lithuania vs Sao Tome and Principe: Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)
Lithuania
87.0%
in 2025
Sao Tome and Principe
87.0%
in 2025
Lithuania rank
107th
Sao Tome and Principe rank
107th
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) over time
- Lithuania
- Sao Tome and Principe
How they compare
Lithuania currently reports 87.0% against 87.0% in Sao Tome and Principe, a difference of 0.0%.
The two have swapped places 5 times across 26 shared years of data; in 2000 it was Lithuania ahead.
Lithuania ranks 107th and Sao Tome and Principe ranks 107th of 194 countries.
Across the 3 decades both report, Lithuania averaged higher in 1 and Sao Tome and Principe in 2.
Head to head by decade
| Decade | Lithuania | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 95.3% | 56.8% | 38.5% | Lithuania |
| 2010s | 93.7% | 95.9% | 2.2% | Sao Tome and Principe |
| 2020s | 89.2% | 91.0% | 1.8% | Sao Tome and Principe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b (hepb3) immunization coverage among 1-year-olds (%), Lithuania or Sao Tome and Principe?
- Lithuania, at 87.0% against 87.0% in Sao Tome and Principe as of 2025.
- What is the difference in hepatitis b (hepb3) immunization coverage among 1-year-olds (%) between Lithuania and Sao Tome and Principe?
- 0.0%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Sao Tome and Principe?
- 26 years are reported by both, from 2000 to 2025.
- How do Lithuania and Sao Tome and Principe rank globally for hepatitis b (hepb3) immunization coverage among 1-year-olds (%)?
- Lithuania ranks 107th and Sao Tome and Principe ranks 107th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.